Application of Implantable Polylactic-Co-Glycolic Acid Microcapsule in Repairing Alveolar Bone Defects

Table 6

Response surface experiment design.

Std	Run	A	B	C	EE%
2	1	1	−1	0	96.88
7	2	−1	0	1	93.49
1	3	−1	−1	0	94.90
16	4	0	0	0	95.78
15	5	0	0	0	96.88
10	6	0	1	−1	96.78
6	7	1	0	−1	96.88
4	8	1	1	0	96.78
11	9	0	−1	1	96.94
5	10	−1	0	−1	96.95
3	11	−1	1	0	96.93
14	12	0	0	0	95.28
9	13	0	−1	−1	96.97
17	14	0	0	0	96.92
8	15	1	0	1	96.97
13	16	0	0	0	96.91
12	17	0	1	1	96.94

“−1”: 20% DCM, PLGA 160 mg/mL, 5% proportion of the internal water phase; “−0”: 30% DCM, PLGA 180 mg/mL, 7.5% proportion of the internal water phase; “1”: 40% DCM, PLGA 200 mg/mL, 10% proportion of the internal water phase.